USPTO Declares Stem Cell Patent Interference
The U.S. Patent and Trademark Office has declared an interference between a patent application by Geron Corp. and a patent owned by Novocell Inc. related to stem cell technology, Geron said...To view the full article, register now.
Already a subscriber? Click here to view full article